Since AngioSoma, Inc. is a publicly traded organization, news on our operations must be disseminated for all shareholders and investors to view at the same time (Regulation FD). We use Business Wire for this disclosure, but we also provide these on our website for expanded images and links to postings of those news releases on other sites.